Aging Problems, Aging Well, Cognitive Change, Gait, Unsteady, Mobility Limitation
Conditions
Keywords
Aquatic exercise, Fall prevention, Functional mobility
Brief summary
The purpose of this study is to assess the effects of an aquatic exercise program on cognition and physical function of older adults.
Interventions
Aquatic exercise class with focus on cognitive and physical exercise
Sponsors
Study design
Eligibility
Inclusion criteria
* Able to ambulate 100 ft independently with or without assistive device * Score greater than or equal to 3 on the Mini-Cog Test * Stable medical condition within one month prior to the study * Stable exercise program within one month prior to the study * Available during study testing and group class times * COVID-19 vaccination * Permission from medical provider to participate in the study
Exclusion criteria
* History of dementia or Alzheimer's * Contraindication to exercise or pool immersion (e.g., unstable cardiovascular conditions, fever, diarrhea, aqua-phobia)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Stroop Effect Test: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | Measure of working memory and attention |
| Trail Making Test A and B: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | Measure of visual scanning and working memory |
| Digit Backwards Test : Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | Measure of working memory capacity |
| Gait Measurements: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | 4 gait conditions (single task gait, dual task gait with head turns, dual task gait with head nods, and dual task gait count backwards by serial 7s). Gait measures collected with Strideway Gait Analysis System. |
| Functional Outcome Measures: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | Timed Up and Go Test, Cognitive Timed Up and Go Test, Single Leg Balance Test, and Four Square Step Test. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Vital Sign measurements: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | Blood pressure and heart rate taken after 5 min supine, immediately upon standing, and 2 min after standing |
| Activities-specific balance confidence scale: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | A structured questionnaire that measures an individuals confidence performing daily activities. The minimum score is 0% (no confidence in balance) to 100% (complete confidence in balance). |
| Anthropometric measurements: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | Height and weight |
| Neurotrophic Growth Factors: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | Serum concentration of brain derived neurotrophic factor and insulin-like growth factor 1 |
| Numeric Pain Rating Scale: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | An 11 point scale for level of pain from 0 (no pain) to 10 (severe pain). |
| Global Rating of Change Questionnaire: Change from baseline to the end of intervention/control period | Measures taken at baseline and again at approximately 9-10 weeks | A 15 point global rating scale for changes in domains, from -7 (a great deal worse); through 0 (no change) to +7 (a great deal better). |
Countries
United States